Figure 2 Reduction of Covid-19 Comorbidity Risk by TPS In a retrospective study of 1,591 severely ill patients with COVID-19, hypertension was the most common comorbidity (49%), followed by cardiovascular disease (21%), hypercholesterolemia (18%), and diabetes (17%) ( Pulmonary Fibrosis COVID-19 patients may have the sequelae of pulmonary fibrosis, with symptoms such as dry cough, fatigue, and dyspnea, leading to weight loss, worsening physical condition, long-term disability, and affecting the patient's quality of life ( During treatment of pulmonary fibrotic rats with EGCG, the rats exhibited reduced inflammation, alveolar damage, and vascular congestion, which were associated with the membrane-stabilizing and antioxidant properties of EGCG, demonstrating that EGCG can act as a potential anti-fibrotic drug ( Diabetes High-risk patients with severe COVID-19 or death have a variety of characteristics, including advanced age and masculinity, as well as potential health problems such as cardiovascular disease, obesity, and diabetes ( Drinking 34 cups of tea per day (600900 mg/day) is often considered to prevent personal obesity metabolic syndrome or reduce disease risk ( Depression In addition to posing a significant threat to physical health, the COVID-19 pandemic also poses a threat to the population's mental health due to increased fear and uncertainty
Nourishing helichrysum extract conditions and strengthens hair while reducing dryness and soothing itchiness that can be the result of repeated color and chemical treatments
10.1016/j.atherosclerosis.2013.11.043 268
Drug design, development and therapy , 9 , 2485-99
10.1007/s12011-021-03009-1[Epub ahead of print]
Healthy Lifestyle: To optimize the benefits of Aqua Skin Veniscy 999 glutathione, maintain a healthy lifestyle
